The University of Missouri (Mizzou) in the US has reached a major milestone in ...

Cells from cancerous tumors can spread, or metastasize, throughout the body. Researchers have long sought to understand what determines where those cells will go and thrive in order to more ...

In a major leap for cancer care at the University of Missouri, the School of Medicine and MU Health Care have launched their ...

Ochsner MD Anderson Cancer Center has begun offering a newly approved, non-invasive treatment for certain liver tumors, making it one of a limited number of hospitals nationwide to provide the ...

Approximately 25% of patients with colorectal cancer present with metastatic disease to the liver at diagnosis, and about 50% develop liver metastases at some point during the course of the disease.

The University of Missouri school of medicine cancer researchers enrolled their first patient in a human clinical trial using Eye90 microspheres and treatment on Monday.

Researchers assess the cost‐effectiveness of nivolumab plus ipilimumab vs lenvatinib or sorafenib for hepatocellular carcinoma from a US healthcare payer perspective.

Isabel Newton, MD, PhD, has been named Chief Medical Officer of Boston Scientific's Interventional Oncology and Embolizatio ...

A cohort study of liver transplant candidates with HCC suggested that local-regional therapy with yttrium-90 transarterial ...

Q4 2025 Earnings Call February 10, 2026 4:30 PM ESTCompany ParticipantsJacquie Ross - Senior Vice President of Treasury ...